CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 57 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,521,000 | -26.7% | 647,174 | -59.5% | 0.00% | -100.0% |
Q3 2019 | $4,806,000 | -27.1% | 1,596,569 | -9.4% | 0.00% | 0.0% |
Q2 2019 | $6,591,000 | -16.6% | 1,762,248 | -10.4% | 0.00% | 0.0% |
Q1 2019 | $7,903,000 | +8.4% | 1,966,042 | -1.0% | 0.00% | 0.0% |
Q4 2018 | $7,289,000 | -57.3% | 1,986,163 | -0.1% | 0.00% | -50.0% |
Q3 2018 | $17,059,000 | -22.3% | 1,988,173 | -0.6% | 0.00% | -33.3% |
Q2 2018 | $21,961,000 | -5.0% | 2,000,099 | -0.2% | 0.00% | -25.0% |
Q1 2018 | $23,114,000 | +628.7% | 2,004,675 | +554.7% | 0.00% | +300.0% |
Q4 2017 | $3,172,000 | -34.9% | 306,216 | +0.1% | 0.00% | 0.0% |
Q3 2017 | $4,876,000 | +16.9% | 305,916 | -11.2% | 0.00% | 0.0% |
Q2 2017 | $4,170,000 | -74.8% | 344,601 | -56.7% | 0.00% | -66.7% |
Q1 2017 | $16,520,000 | +88.6% | 795,396 | +29.8% | 0.00% | +50.0% |
Q4 2016 | $8,760,000 | -16.6% | 612,577 | -4.0% | 0.00% | 0.0% |
Q3 2016 | $10,500,000 | +19.3% | 638,297 | +0.5% | 0.00% | 0.0% |
Q2 2016 | $8,799,000 | -1.7% | 634,888 | -0.0% | 0.00% | 0.0% |
Q1 2016 | $8,949,000 | – | 634,988 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $11,661,000 | 2.42% |
Telemetry Investments, L.L.C. | 189,081 | $673,000 | 1.14% |
CHI Advisors LLC | 490,877 | $1,748,000 | 0.49% |
BVF INC/IL | 1,943,712 | $6,920,000 | 0.27% |
Orbimed Advisors | 6,767,584 | $24,093,000 | 0.21% |
Novo Holdings A/S | 847,906 | $3,019,000 | 0.13% |
Golden Green, Inc. | 19,539 | $70,000 | 0.06% |
ALGERT GLOBAL LLC | 15,467 | $55,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $476,000 | 0.01% |
Hikari Power Ltd | 19,959 | $71,000 | 0.01% |